Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Shares, nominal value (euro)0.12 per share
-
Shares outstanding
-
67,811,197
-
Total 13F shares
-
9,273,979
-
Share change
-
+393,018
-
Total reported value
-
$44,122,000
-
Put/Call ratio
-
11%
-
Price per share
-
$4.76
-
Number of holders
-
37
-
Value change
-
+$4,508,577
-
Number of buys
-
14
-
Number of sells
-
17
Institutional Holders of InflaRx N.V. - Common Shares, nominal value (euro)0.12 per share (IFRX) as of Q4 2021
As of 31 Dec 2021,
InflaRx N.V. - Common Shares, nominal value (euro)0.12 per share (IFRX) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,273,979 shares.
The largest 10 holders included
SUVRETTA CAPITAL MANAGEMENT, LLC, Sofinnova Investments, Inc., ORBIMED ADVISORS LLC, MORGAN STANLEY, Walleye Capital LLC, Laurion Capital Management LP, Ikarian Capital, LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., Bank Julius Baer & Co. Ltd, Zurich, and Invesco Ltd..
This page lists
37
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.